LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,507,000 | -29.9% | 66,733 | -3.7% | 0.00% | -20.0% |
| Q4 2021 | $10,709,000 | +6.6% | 69,329 | -3.8% | 0.01% | -16.7% |
| Q3 2021 | $10,045,000 | +43.2% | 72,099 | +34.8% | 0.01% | +50.0% |
| Q2 2021 | $7,017,000 | -19.3% | 53,485 | -6.2% | 0.00% | -20.0% |
| Q1 2021 | $8,693,000 | -41.5% | 57,021 | -61.8% | 0.01% | -44.4% |
| Q4 2020 | $14,856,000 | -5.7% | 149,386 | -9.6% | 0.01% | -18.2% |
| Q3 2020 | $15,746,000 | -17.8% | 165,196 | -3.6% | 0.01% | -26.7% |
| Q2 2020 | $19,167,000 | +39.9% | 171,365 | -9.0% | 0.02% | +15.4% |
| Q1 2020 | $13,696,000 | -31.0% | 188,337 | -1.0% | 0.01% | -7.1% |
| Q4 2019 | $19,847,000 | +30.0% | 190,304 | +24.1% | 0.01% | +16.7% |
| Q3 2019 | $15,268,000 | -28.4% | 153,381 | -17.8% | 0.01% | -33.3% |
| Q2 2019 | $21,311,000 | -9.5% | 186,695 | -0.3% | 0.02% | -10.0% |
| Q1 2019 | $23,540,000 | +23.7% | 187,253 | +33.6% | 0.02% | +5.3% |
| Q4 2018 | $19,026,000 | -60.6% | 140,204 | -20.2% | 0.02% | -54.8% |
| Q3 2018 | $48,241,000 | +17.3% | 175,746 | -11.5% | 0.04% | +7.7% |
| Q2 2018 | $41,120,000 | +17.9% | 198,485 | -6.0% | 0.04% | +14.7% |
| Q1 2018 | $34,888,000 | +37.0% | 211,239 | +13.6% | 0.03% | +36.0% |
| Q4 2017 | $25,459,000 | -7.4% | 185,926 | -8.0% | 0.02% | -16.7% |
| Q3 2017 | $27,506,000 | +20.8% | 202,029 | +7.7% | 0.03% | +11.1% |
| Q2 2017 | $22,774,000 | +31.0% | 187,594 | +14.2% | 0.03% | 0.0% |
| Q1 2017 | $17,379,000 | -10.1% | 164,200 | -13.6% | 0.03% | 0.0% |
| Q4 2016 | $19,321,000 | +6.3% | 190,149 | +6.8% | 0.03% | 0.0% |
| Q3 2016 | $18,172,000 | -4.9% | 178,050 | +11.2% | 0.03% | -10.0% |
| Q2 2016 | $19,103,000 | -8.1% | 160,168 | -17.5% | 0.03% | -11.8% |
| Q1 2016 | $20,795,000 | +500.1% | 194,183 | +507.7% | 0.03% | +466.7% |
| Q4 2015 | $3,465,000 | +99.1% | 31,955 | +57.3% | 0.01% | +100.0% |
| Q3 2015 | $1,740,000 | -14.2% | 20,310 | +1.0% | 0.00% | -25.0% |
| Q2 2015 | $2,028,000 | +54.7% | 20,104 | +18.2% | 0.00% | +33.3% |
| Q1 2015 | $1,311,000 | +163.8% | 17,008 | +82.3% | 0.00% | +200.0% |
| Q4 2014 | $497,000 | +41.6% | 9,331 | +65.5% | 0.00% | 0.0% |
| Q2 2014 | $351,000 | -22.5% | 5,639 | -16.3% | 0.00% | 0.0% |
| Q1 2014 | $453,000 | +85.7% | 6,738 | +45.4% | 0.00% | 0.0% |
| Q4 2013 | $244,000 | -26.7% | 4,633 | -39.7% | 0.00% | 0.0% |
| Q3 2013 | $333,000 | -52.6% | 7,687 | -59.0% | 0.00% | -50.0% |
| Q2 2013 | $702,000 | – | 18,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |